Cytotoxic T Lymphocyte Lysis Inhibited by Viable HIV Mutants
暂无分享,去创建一个
P. Klenerman | B. Larder | R. Phillips | A. McMichael | U. Meier | P Klenerman | W James | U C Meier | P Griffin | B Köppe | B Larder | A McMichael | R Phillips | W. James | P. Griffin | Brendan Larder | Philip Griffin | Britta Köppe | Britta Köppe | R. Phillips
[1] J. Coffin. Lines drawn in epitope wars , 1995, Nature.
[2] P. Klenerman,et al. Immunogenic HIV variant peptides that bind to HLA-B8 can fail to stimulate cytotoxic T lymphocyte responses. , 1995, Journal of immunology.
[3] Paul Kellam,et al. Convergent combination therapy can select viable multidrug-resistant HIV-1 in vitro , 1993, Nature.
[4] Paul M. Allen,et al. Partial T cell signaling: Altered phospho-ζ and lack of zap70 recruitment in APL-induced T cell anergy , 1994, Cell.
[5] Nigel Bosworth,et al. Scintillation proximity assay , 1989, Nature.
[6] P. Klenerman,et al. The effects of natural altered peptide ligands on the whole blood cytotoxic T lymphocyte response to human immunodeficiency virus , 1995, European journal of immunology.
[7] L. Samelson,et al. Zeta phosphorylation without ZAP-70 activation induced by TCR antagonists or partial agonists , 1995, Science.
[8] W. Paul. Can the immune response control HIV infection? , 1995, Cell.
[9] P. Illei,et al. Definition of the range and distribution of human immunodeficiency virus macrophage tropism using PCR-based infectivity measurements. , 1994, The Journal of general virology.
[10] M. Bevan,et al. Clone-specific T cell receptor antagonists of major histocompatibility complex class I-restricted cytotoxic T cells , 1993, The Journal of experimental medicine.
[11] A. Sette,et al. Natural variants of cytotoxic epitopes are T-cell receptor antagonists for antiviral cytotoxic T cells , 1994, Nature.
[12] H. Temin,et al. Spontaneous variation and synthesis in the U3 region of the long terminal repeat of an avian retrovirus , 1982, Journal of virology.
[13] H. Temin,et al. Retrovirus variation and reverse transcription: abnormal strand transfers result in retrovirus genetic variation. , 1993, Proceedings of the National Academy of Sciences of the United States of America.
[14] Andreas Meyerhans,et al. Temporal fluctuations in HIV quasispecies in vivo are not reflected by sequential HIV isolations , 1989, Cell.
[15] J. Eberle,et al. A new method for measuring reverse transcriptase activity by ELISA. , 1992, Journal of virological methods.
[16] U. Koszinowski,et al. Efficient processing of an antigenic sequence for presentation by MHC class I molecules depends on its neighboring residues in the protein , 1991, Cell.
[17] L. Comstock,et al. The tac promoter: a functional hybrid derived from the trp and lac promoters. , 1983, Proceedings of the National Academy of Sciences of the United States of America.
[18] Martin A. Nowak,et al. Antigenic oscillations and shifting immunodominance in HIV-1 infections , 1995, Nature.
[19] W. James,et al. A rat CD4 mutant containing the gp120-binding site mediates human immunodeficiency virus type 1 infection , 1993, The Journal of experimental medicine.
[20] A. Townsend,et al. Antigen recognition by class I-restricted T lymphocytes. , 1989, Annual review of immunology.
[21] R. Young,et al. Long-term culture and fine specificity of human cytotoxic T-lymphocyte clones reactive with human immunodeficiency virus type 1. , 1989, Proceedings of the National Academy of Sciences of the United States of America.
[22] S D Kemp,et al. Multiple mutations in HIV-1 reverse transcriptase confer high-level resistance to zidovudine (AZT). , 1989, Science.
[23] M. Bevan. The major histocompatibility complex determines susceptibility to cytotoxic T cells directed against minor histocompatibility antigens , 1975, The Journal of experimental medicine.
[24] P. Allen,et al. Tickling the TCR: selective T-cell functions stimulated by altered peptide ligands. , 1993, Immunology today.
[25] P. Simmonds,et al. Detection, quantification and sequencing of HIV-1 from the plasma of seropositive individuals and from factor VIII concentrates. , 1991, AIDS.
[26] J. Levy,et al. Impaired cytotoxic T lymphocyte recognition due to genetic variations in the main immunogenic region of the human immunodeficiency virus 1 NEF protein , 1994, The Journal of experimental medicine.
[27] B. Larder,et al. Infectious potential of human immunodeficiency virus type 1 reverse transcriptase mutants with altered inhibitor sensitivity. , 1989, Proceedings of the National Academy of Sciences of the United States of America.
[28] Charles R. M. Bangham,et al. Human immunodeficiency virus genetic variation that can escape cytotoxic T cell recognition , 1991, Nature.
[29] R. Koup. Virus escape from CTL recognition , 1994, The Journal of experimental medicine.